Group Characteristics and Differences from Benzodiazepines
The pharmacological group of non-benzodiazepine anxiolytics unites drug compounds that differ cardinally from classical tranquilizers. The primary feature of these agents is that their chemical structure and sites of action in the body are distinct, allowing them to avoid many of the undesirable effects traditionally accompanying benzodiazepine use.
Modern agents in this category exhibit selective anxiolytic activity aimed directly at relieving anxiety. At the same time, they completely lack the following properties:
- pronounced sedative action;
- central muscle relaxation;
- anticonvulsant activity.
Azaspirodecandione Derivatives: Buspirone
A prominent representative of this subgroup is buspirone. Its pharmacological profile is based on interaction with the serotonergic system:
- The drug acts as a partial agonist of 5-HT1A receptors.
- The substance is demonstrably independent of the GABAergic system and does not affect benzodiazepine receptors.
The clinical use of buspirone requires taking its pharmacodynamic characteristics into account. The anxiolytic effect does not develop immediately: there is a delayed or latent period, during which the therapeutic effect manifests only after two weeks of regular use. A crucial advantage of the medication is the minimal severity of tolerance and an almost complete absence of the risk of developing drug dependence.
Drugs of Other Chemical Groups
A separate category includes agents with additional unique pharmacological properties that determine a physician's choice when a patient has concomitant somatic pathology.
- Benzoclidine (Oxylidine) exerts a moderate blocking effect on ganglia and adrenoceptors, demonstrating a pronounced hypotensive effect. Like other non-benzodiazepine agents, it lacks a central muscle-relaxant effect, making it an optimal choice for patients with hypertension and cerebrovascular disorders.
- Mebicar is characterized by moderate tranquilizing activity. It belongs to the group of so-called "daytime" tranquilizers because its administration is not accompanied by daytime drowsiness, lethargy, or reduced concentration.